{"slug":"semaglutide-tirzepatide","verification":{"valid":true,"entries":2,"head":"d71ea45d6bd6822490f4c50e27488cf00c758e96a4a4d4bf0c97e93dfaffe4a8"},"energy":{"passes":2,"tokens_in":18069,"tokens_out":3321,"tokens_total":21390,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"d71ea45d6bd6822490f4c50e27488cf00c758e96a4a4d4bf0c97e93dfaffe4a8"},"provenance":[{"ts":"2026-06-30T00:18:02.856Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Semaglutide for Tirzepatide\nSlug: semaglutide-tirzepatide\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"dual_compound\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"tirzepatide\",\"name\":\"Tirzepatide\"},{\"id\":\"semaglutide\",\"name\":\"Semaglutide\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"tirzepatide\",\"name\":\"Tirzepatide\",\"section_title\":\"Why Tirzepatide might help you\",\"layer\":\"metabolic load / body weight\",\"steps\":[\"**What keeps failing:** Same mechanical overload pattern as other GLP-1 contexts at higher body weight.\",\"**What Tirzepatide is studied to do:** Studied for GLP-1/GIP weight loss — load reduction on spine and joints.\",\"**Therefore for you:** If that layer is part of your problem, Tirzepatide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.\"],\"prose\":\"1. **What keeps failing:** Same mechanical overload pattern as other GLP-1 contexts at higher body weight.\\n2. **What Tirzepatide is studied to do:** Studied for GLP-1/GIP weight loss — load reduction on spine and joints.\\n3. **Therefore for you:** If that layer is part of your problem, Tirzepatide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.\"},{\"peptide\":\"semaglutide\",\"name\":\"Semaglutide\",\"section_","response":"{\n  \"slug\": \"semaglutide-tirzepatide\",\n  \"title\": \"Semaglutide and Tirzepatide: Human Trial Evidence on Weight Loss and Load Reduction Pathways\",\n  \"body\": \"## What's breaking down\\n\\nHigher body weight creates ongoing mechanical overload on weight-bearing tissues. Each extra pound of body mass transmits roughly four pounds of compressive force through the lumbar spine during upright activity. Over time this pattern can accelerate disc height loss, joint surface wear, and connective tissue strain. Metabolic stress from excess adiposity may further slow natural repair processes in these tissues. Both semaglutide and tirzepatide are studied primarily for their effects on body weight; any downstream tissue benefit would flow from reduced load rather than direct repair signaling.\\n\\n## Why Tirzepatide might help you\\n\\n1. What keeps failing: The same mechanical overload pattern seen in other GLP-1 contexts, but potentially amplified at higher starting body weight.\\n2. What Tirzepatide is studied to do: Dual GLP-1/GIP agonism produces substantial weight reduction in human trials.\\n3. Therefore for you: If excess body weight contributes to your tissue overload, tirzepatide is discussed because it targets the load-reduction layer — not because it masks symptoms.\\n\\n## Why Semaglutide might help you\\n\\n1. What keeps failing: Weight-related overload on joints and discs plus metabolic stress that can limit repair capacity.\\n2. What Semaglutide is studied to do: GLP-1 agonism drives clinically meaningful weight loss in human trials and has been linked to reduced knee pain scores in participants with obesity and osteoarthritis.\\n3. Therefore for you: If that mechanical layer is active in your situation, semaglutide is discussed for its documented effect on body weight and associated load — not symptom suppression alone.\\n\\n## How these fit together\\n\\nEach compound above targets a different degeneration layer. Together they are a stack — not copies of the same mechanism.\\n- Tir","tokens_in":18069,"tokens_out":3321,"cost":0,"prev":"genesis","hash":"ad6f25ff2c7f2f5743efab61986d00a389340ce51107018141b4b69b744d92e2"},{"ts":"2026-07-17T02:41:50.087Z","model":"owner","action":"voxel_divide","prompt":"","input":"semaglutide-tirzepatide","response":"22 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"ad6f25ff2c7f2f5743efab61986d00a389340ce51107018141b4b69b744d92e2","hash":"d71ea45d6bd6822490f4c50e27488cf00c758e96a4a4d4bf0c97e93dfaffe4a8"}]}